Kazia Therapeutics Limited logo

KZIAKazia Therapeutics Limited

KZIA Stock Price, Valuation & Chart | Kazia Therapeutics Limited

Compare

KZIA Historical price chart

KZIA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization20.43M
PE Ratio-2.65
EPS-4.76
Trading Volume359.14K
Today's High/Low13.13/12.05
Dividend Yield0.00
52 Week High/Low17.4/4.86
Shares Outstanding1.62M
KZIA Financial Statement
KZIA Analyst ratings
KZIA Analysis & performance metrics

KZIA Company profile

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule,…

KZIA Management team

Management
Jeffrey Bonacorda
Vice President of Finance & Controller
Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC
Company Secretary
John Edwin Friend II, M.D.CEO
Chief Executive Officer, MD & Director
Total 3 executives

KZIA Frequently asked questions

What is Kazia Therapeutics Limited (KZIA) Stock Price?

Current stock price of Kazia Therapeutics Limited (KZIA) stock is $12.610. The stock price is -0.16% lower in the session. The intraday range can be seen from this page. Volume of Kazia Therapeutics Limited (KZIA) stock is 359.14K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Kazia Therapeutics Limited (KZIA) stock price going up or down today?

The stock price of Kazia Therapeutics Limited (KZIA) can change with earnings, company news, and overall market sentiment. Kazia Therapeutics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kazia Therapeutics Limited stock expensive at its current price?

Whether Kazia Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KZIA on this page is -2.65. EPS on this page is -4.76. Compare those figures with peers and growth expectations before deciding if the current Kazia Therapeutics Limited price is justified.

How has the stock price of Kazia Therapeutics Limited (KZIA) performed historically?

Historical performance for Kazia Therapeutics Limited (KZIA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KZIA reacted to past earnings and market events.

Should I buy Kazia Therapeutics Limited (KZIA) stock, at this price?

Buying Kazia Therapeutics Limited (KZIA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.